BioStem Technologies, a Pompano Beach-based innovator in regenerative therapies, has secured $2.5M in new funding. The company specializes in the development, manufacture, and commercialization of allografts derived from perinatal tissue, leveraging its proprietary BioRetain processing method. This method is designed to maintain growth factors and preserve tissue structure, applying the latest research in regenerative medicine.
The firm's quality management system and standard operating procedures are accredited by the American Association of Tissue Banks (AATB), with products like VENDAJE and VENDAJE AC processed at its FDA registered site in Pompano Beach, Florida.
